GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities
Newly established R&D division this year is expected to provide full-scale in-house R&D in addition to clinical sample analysis Including blockbuster drugs such as ‘Keytruda’ and ‘Yervoy’, GCCL offers tailored clinical trial analysis services for biosimilar development YONGIN, South Korea, July 16, 2024 /PRNewswire/ — GCCL, a clinical trial sample analysis institution, has proactively developed pharmacokinetic … Read more
